Cook Meredith's Form 4 filing
Ani Pharmaceuticals Inc (ANIP) · filed Feb 18, 2025
- Accession no.
- 0001938861-25-000004
- Filed
- Feb 18, 2025
- Trade date
- Feb 12-14, 2025
- Filing delay
- 6 daysLate
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions. Open-market sales total $23.8K. It was filed 6 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cook MeredithCIK 0001938861 | Officer (SR. VP, GENERAL COUNSEL & SEC.) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 12, 2025 | Common Stock | AGrant or awardAcquired | +16,974 | $0.00 | $0 | 72,562 | Direct | |
| Feb 12, 2025 | Common Stock | AGrant or awardAcquired | +11,316 | $0.00 | $0 | 83,878 | Direct | |
| Feb 13, 2025 | Common Stock | SSaleDisposed | −400 | $59.54 | −$23,816 | 83,478 | Direct | |
| Feb 14, 2025 | Common Stock | FTax withholdingDisposed | −1,434 | $58.92 | −$84,491.28 | 82,044 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.